Work

Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

Year: 2025

Type: article

Source: Expert Review of Cardiovascular Therapy

DOI: 10.1080/14779072.2025.2464180

Authors: Manuel Anguita, Francisco Marín, Javier Soto, Susana Fernández de Cabo, Darío Rubio-Rodríguez, Carlos Rubio-Terrés

Institutions: Instituto Maimónides de Investigación Biomédica de Córdoba, University of Córdoba, Centro de Investigación en Red en Enfermedades Cardiovasculares, Pfizer (United States)

Language: English

Topic: Atrial Fibrillation Management and Outcomes

Subfield: Cardiology and Cardiovascular Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Bristol-Myers Squibb

OpenAlex ID: W4407256166

FWCI:

Cites: 38

Cited by:

Related to: 10